AMERICAN ARBITRATION ASSOCIATION (“AAA”) COMMERCIAL ARBITRATION TRIBUNAL AAA Case No. 01-17-0004-0880 UNITED STATES ANTI-DOPING AGENCY (USADA), Claimant and FINAL AWARD ALBERTO SALAZAR, Respondent. TABLE OF CONTENTS Page I. INTRODUCTION ........................................................................................................... 1 II. THE PARTIES................................................................................................................. 2 III. JURISDICTION .............................................................................................................. 3 IV. PROCEDURAL HISTORY............................................................................................. 3 A. Notice Letter ........................................................................................................ 3 B. Charging Letter .................................................................................................... 3 C. Procedural Motions and Hearing ......................................................................... 5 1. Preliminary Hearing and Scheduling Order No. 1 ................................... 5 a. Respondent’s Motion for More Definite Statement of Claims .......................................................................................... 5 b. USADA’s Motion to Amend Claim ............................................ 6 c. USADA’s Motion for Issuance of Subpoenas and/or to Move Location of Arbitration to Houston, Texas ........................ 6 2. Scheduling Order No. 2 ........................................................................... 7 3. Procedural Order No. 3 ............................................................................ 8 4. Procedural Order No. 4 ............................................................................ 9 5. Procedural Order No. 5 ............................................................................ 9 6. Procedural Order No. 6 ............................................................................ 9 7. Procedural Order No. 7 .......................................................................... 10 8. Procedural Order No. 8 .......................................................................... 10 9. Procedural Order No. 9 .......................................................................... 10 10. Procedural Order No. 10 ........................................................................ 10 11. Procedural Order No. 11 ........................................................................ 11 12. Procedural Order No. 12 ........................................................................ 11 13. Procedural Order No. 13 ........................................................................ 11 14. Procedural Order No. 14 ........................................................................ 12 15. Pre/Post-Hearing Briefs and In-Person Hearings .................................. 12 V. APPLICABLE RULES .................................................................................................. 13 VI. WITNESS LIST ............................................................................................................. 21 A. For USADA ....................................................................................................... 21 B. For Respondent: ................................................................................................. 22 -i- TABLE OF CONTENTS (continued) Page VII. STATUTE OF LIMITATIONS ..................................................................................... 24 A. Submissions ....................................................................................................... 24 1. USADA’s Submissions .......................................................................... 24 2. Respondent’s Submissions..................................................................... 24 B. Decision and Reasoning – Statute of Limitations .............................................. 24 VIII. BACKGROUND ........................................................................................................... 25 IX. THE L-CARNITINE INFUSIONS/INJECTIONS ........................................................ 25 A. Charges .............................................................................................................. 25 B. Factual Background ........................................................................................... 26 1. L-carnitine Research .............................................................................. 26 2. Magness Involvement ............................................................................ 27 3. Magness Receives L-carnitine Infusion ................................................. 31 4. Magness as Athlete ................................................................................ 33 5. NOP Athletes ......................................................................................... 34 6. Email Exchanges Regarding Infusions and Injections........................... 39 7. Alteration of Medical Records ............................................................... 43 8. Dr. Maguadog and the Compounding Corner Pharmacy ...................... 45 C. Administration and/or Attempted Administration – L-carnitine ....................... 46 1. Magness Infusion - Administration ....................................................... 47 a. USADA Submissions................................................................. 47 b. Respondent’s Submissions......................................................... 51 2. Decision and Reasoning - L-Carnitine – Administration – Magness Infusion ................................................................................... 54 3. Administration and/or Attempted Administration – L-carnitine - NOP Athletes ......................................................................................... 57 a. USADA Submissions................................................................. 57 b. Respondent’s Submissions......................................................... 62 4. Decision and Reasoning - Administration and/or Attempted Administration – L-Carnitine - NOP Athletes ....................................... 68 D. Complicity – L-carnitine – Magness Infusion and NOP Athletes ..................... 72 1. USADA’s Submissions - Complicity .................................................... 72 -ii- TABLE OF CONTENTS (continued) Page a. Magness and NOP Athletes Infusion ......................................... 72 b. Intent .......................................................................................... 73 2. Respondent’s Submissions..................................................................... 74 a. Magness and NOP Athletes Infusion ......................................... 74 b. Intent .......................................................................................... 76 3. Decision and Reasoning - Complicity - L-carnitine – Magness Infusion and NOP Athletes .................................................................... 77 a. Magness Infusion ....................................................................... 78 b. NOP Athletes ............................................................................. 79 E. Tampering and/or Attempted Tampering - L-Carnitine .................................... 80 1. Submissions – Tampering and Attempted Tampering – L- Carnitine ................................................................................................. 81 a. Respondent’s Email Instructions to NOP Athletes Regarding L-carnitine ................................................................ 81 b. Magness Role ............................................................................. 84 c. Medical Records ........................................................................ 85 2. Decision and Reasoning – Tampering and/or Attempted Tampering – L-Carnitine ....................................................................... 86 a. Magness Role and Medical Records .......................................... 87 b. Respondent’s Email Instructions to NOP Athletes Regarding L-carnitine ................................................................ 87 X. RESPONDENT’S PERSONAL USE OF TESTOSTERONE ...................................... 88 A. Charges .............................................................................................................. 88 B. Factual Background ........................................................................................... 89 1. Respondent’s Use of Testosterone ......................................................... 89 2. Respondent’s Role in Medical Treatment of NOP Athletes – Focus on Increasing Testosterone Levels .............................................. 93 C. Submissions – Possession of Testosterone – Personal Use ............................... 95 1. USADA’s Submissions .......................................................................... 95 a. In Connection with an Athlete, Competition or training ........... 96 b. Acceptable Justification ............................................................. 97 2. Respondent’s Submissions..................................................................... 98 -iii- TABLE OF CONTENTS (continued) Page a. In Connection with an Athlete, Competition or training ........... 98 b. Acceptable Justification ........................................................... 100 D. Decision and